In this study, we comprehensively characterized the expression profile of TRPM4 across multiple tumor types through systematic bioinformatics analysis, with a particular focus on evaluating its clinical relevance and prognostic value in clear cell renal cell carcinoma (KIRC). This evidence concerns the gene TRPM4 and clear cell renal carcinoma.